High-grade Extra Pulmonary Neuroendocrine Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which High-grade Extra Pulmonary Neuroendocrine Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 2

NCT04042714

TAS-102 in Extrapulmonary Neuroendocrine Carcinoma

The purpose of this study is to test the safety and efficacy of drug, TAS-102 (trifluridine/tipiracil), in patients with extrapulmonary (outside the lung) high-…

United States14 participantsStarted 2019-08-15

Treatment: All patients- TAS-102